Categories Earnings Calls, Health Care

Biogen, Inc. (BIIB) Q4 2020 Earnings Call

Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021

Corporate Participants:

Mike Hencke — Director, Investor Relations

Michel Vounatsos — Chief Executive Officer

Alfred W. Sandrock — Executive Vice President

Michael McDonnell — Executive Vice President Chief Financial Officer

Analysts:

Max Skor — Morgan Stanley — Analyst

Terence Flynn — Goldman Sachs — Analyst

Marc Goodman — SVB Leerink — Analyst

Umer Raffat — Evercore — Analyst

Cory Kasimov — JPMorgan — Analyst

Evan Seigerman — Credit Suisse — Analyst

Michael Yee — Jefferies — Analyst

Paul Matteis — Stifel — Analyst

Phil Nadeau — Cowen & Company — Analyst

Jay Olson — Oppenheimer — Analyst

Robyn Karnauskas — Truist — Analyst

Salim Syed — Mizuho — Analyst

_________
To read the full earnings call transcript, click here

Most Popular

ACN Earnings: All you need to know about Accenture’s Q2 2023 earnings results

Accenture (NYSE: ACN) reported second quarter 2023 earnings results today. Total revenues increased 5% year-over-year to $15.8 billion. Net income attributable to Accenture plc was $1.52 billion, or $2.39 per

Here’s how FedEx (FDX) plans to soften the impact of volume declines on its business

Shares of FedEx Corporation (NYSE: FDX) stayed green on Wednesday. The stock has gained 26% year-to-date. The company faced a challenging environment in the third quarter of 2023 which took

Walgreens Boots Alliance (WBA) shifts to expansion mode. Will it pay off?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better align with the transformation the healthcare space is witnessing. Currently,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top